238756-47-3

Usage

Uses

Used in Pharmaceutical Industry:
2-Chloroquinolin-6-amine is used as an intermediate in the synthesis of pharmaceutical compounds for its potential applications in the development of new drugs. Its antiproliferative and cytotoxic properties make it a promising candidate for drug discovery and research.
Used in Agrochemical Industry:
In the agrochemical industry, 2-chloroquinolin-6-amine is utilized as an intermediate in the synthesis of agrochemicals, contributing to the development of new pesticides.
Used in Research and Development:
2-Chloroquinolin-6-amine is employed as a building block for the creation of various heterocyclic compounds, which are essential in the advancement of research and development in the fields of chemistry and biology.
Used in Fluorescent Dyes Preparation:
2-CHLOROQUINOLIN-6-AMINE is also used in the preparation of fluorescent dyes, owing to its chemical properties that make it suitable for such applications.
Used as a Reagent in Organic Synthesis:
2-Chloroquinolin-6-amine serves as a reagent in organic synthesis, facilitating various chemical reactions and processes in the synthesis of different organic compounds.

Upstream product

• 13675-92-8 6-nitroquinoline-N-oxide 
• 29969-57-1 2-chloro-6-nitroquinoline 

Downstream Products

• 205055-71-6 2-chloro-6-chlorosulfonylquinoline 

Relevant academic research and scientific papers

PICOLINAMIDE DERIVATIVES USEFUL AS AGRICULTURAL FUNGICIDES

The present invention relates to picolinic acid derivatives that are useful in treating fungal diseases, particularly in plants.

Synthesis of mono-substituted derivatives of 6-aminoquinoline

Several 6-aminoquinoline derivatives, which could be used in drug design, have been synthesized. The reaction conditions were comparatively studied, and the p-chloroaniline was used as optimum oxidant in Skraup-Doebner-Von Miller reaction. The nitro group was reduced effectively by SnCl2 with no halo-removed occurred.

Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease

Disclosed herein are sulfonamide compounds of Formula VII as described herein. Methods and compositions are disclosed for treating disease states including, but not limited to cancers, autoimmune diseases, tissue damage, central nervous system disorders, neurodegenerative disorders, fibrosis, bone disorders, polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, cardiovascular conditions, and disorders in which angiogenesis play a role in pathogenesis, using the compounds of the invention. In addition, methods of modulating the activity of histone deacetylase (HDAC) are also disclosed.

THERAPEUTIC AGENTS I

Compounds of formula(I), processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders, and pharmaceutical compositions containing them.